L G Kennedy1, R Will, A Calin. 1. Royal National Hospital for Rheumatic Diseases, Upper Borough Walls, Bath, UK.
Abstract
OBJECTIVE: To investigate the interrelated effect of phenotypic expression [i.e., primary ankylosing spondylitis (1 degree AS) or disease secondary to psoriasis (Ps) AS or inflammatory bowel disease (IBD)AS], age at onset, sex and inheritance of responsible genes in AS. METHODS: Three studies were performed to evaluate 1949 subjects with AS. Subgroups of the patients were formed for each study depending on disease type (1 degree AS = 1695; Ps AS = 173; IBD AS = 81), nature of inheritance or age at onset of AS symptoms. These groups were further subdivided to assess the effect of sex. RESULTS: The sex ratio of the entire group was 2.6:1 in favor of men. However, IBD AS had an equal sex distribution as does IBD alone. By contrast, Ps, which has an equal sex ratio as a lone event or in association with arthritis, resulted in a male dominance of 4.1:1 when it occurred as Ps AS. Women with IBD AS had a significantly younger onset compared to women with 1 degree AS [mean onset 21.7 years (SD 6.65) vs mean onset 24.4 years (SD 9.79), respectively; p = 0.019]. A younger age at onset was found in women with familial disease [mean 22.2 years (SD 7.55)] compared with the mean onset of sporadic disease in women [24.5 years (SD 10.0); p = 0.0059]. There was a progressive fall in the sex ratio as the age at onset increased (p = 0.053). For example: M:F ratio of < 20 years old was 3:1 compared to 1.8:1 for those with an onset of > 40 years. CONCLUSION: Sex ratio and age at onset are influenced both by each other and such factors as disease type and familial versus sporadic occurrence. These data help provide a predictable pattern of disease in spondyloarthropathy.
OBJECTIVE: To investigate the interrelated effect of phenotypic expression [i.e., primary ankylosing spondylitis (1 degree AS) or disease secondary to psoriasis (Ps) AS or inflammatory bowel disease (IBD)AS], age at onset, sex and inheritance of responsible genes in AS. METHODS: Three studies were performed to evaluate 1949 subjects with AS. Subgroups of the patients were formed for each study depending on disease type (1 degree AS = 1695; Ps AS = 173; IBD AS = 81), nature of inheritance or age at onset of AS symptoms. These groups were further subdivided to assess the effect of sex. RESULTS: The sex ratio of the entire group was 2.6:1 in favor of men. However, IBD AS had an equal sex distribution as does IBD alone. By contrast, Ps, which has an equal sex ratio as a lone event or in association with arthritis, resulted in a male dominance of 4.1:1 when it occurred as Ps AS. Women with IBD AS had a significantly younger onset compared to women with 1 degree AS [mean onset 21.7 years (SD 6.65) vs mean onset 24.4 years (SD 9.79), respectively; p = 0.019]. A younger age at onset was found in women with familial disease [mean 22.2 years (SD 7.55)] compared with the mean onset of sporadic disease in women [24.5 years (SD 10.0); p = 0.0059]. There was a progressive fall in the sex ratio as the age at onset increased (p = 0.053). For example: M:F ratio of < 20 years old was 3:1 compared to 1.8:1 for those with an onset of > 40 years. CONCLUSION: Sex ratio and age at onset are influenced both by each other and such factors as disease type and familial versus sporadic occurrence. These data help provide a predictable pattern of disease in spondyloarthropathy.
Authors: P Trontzas; A Andrianakos; S Miyakis; K Pantelidou; E Vafiadou; V Garantziotou; C Voudouris Journal: Clin Rheumatol Date: 2005-04-29 Impact factor: 2.980
Authors: Hellen M S de Carvalho; Adriana B Bortoluzzo; Célio R Gonçalves; José Antonio Braga da Silva; Antonio Carlos Ximenes; Manoel B Bértolo; Sandra L E Ribeiro; Mauro Keiserman; Rita Menin; Thelma L Skare; Sueli Carneiro; Valderílio F Azevedo; Walber P Vieira; Elisa N Albuquerque; Washington A Bianchi; Rubens Bonfiglioli; Cristiano Campanholo; Izaias P Costa; Angela P Duarte; Maria Bernadete O Gavi; Charles L Kohem; Nocy H Leite; Sonia A L Lima; Eduardo S Meirelles; Ivânio A Pereira; Marcelo M Pinheiro; Elizandra Polito; Gustavo G Resende; Francisco Airton C Rocha; Mittermayer B Santiago; Maria de Fátima L C Sauma; Percival D Sampaio-Barros Journal: Clin Rheumatol Date: 2011-12-28 Impact factor: 2.980
Authors: Anatoly V Rubtsov; Kira Rubtsova; Aryeh Fischer; Richard T Meehan; Joann Z Gillis; John W Kappler; Philippa Marrack Journal: Blood Date: 2011-05-04 Impact factor: 22.113
Authors: Wonuk Lee; John D Reveille; John C Davis; Thomas J Learch; Michael M Ward; Michael H Weisman Journal: Ann Rheum Dis Date: 2006-11-24 Impact factor: 19.103
Authors: Sara Khan; Divya Shridharmurthy; Kate L Lapane; Catherine Dube; Jonathan Kay; Esther Yi; Shao-Hsien Liu Journal: Clin Rheumatol Date: 2022-01-06 Impact factor: 2.980
Authors: F Bandinelli; G Salvadorini; A Delle Sedie; L Riente; S Bombardieri; M Matucci-Cerinic Journal: Clin Rheumatol Date: 2015-08-04 Impact factor: 2.980